...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.
【24h】

The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.

机译:聚维酮K17对尼莫地平和聚乙二醇固体分散体储存稳定性的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Previous studies revealed that solid dispersions containing nimodipine and polyethylene glycol 2000 can be effectively prevented from recrystallization by adding povidone K17. These systems are characterized by a high dissolution rate and a remarkable supersaturation of the drug in the dissolution media. It is still unknown if these characteristics are achievable with all polyethylene glycol and povidone mixtures. The objective of the present study is to find out, whether povidone K17 has to be dissolved in melted polyethylene glycol during the preparation process of solid dispersions by the melting method in order to avoid recrystallization of the drug and to ensure storage stability. Solid dispersions consisting of 20% (m/m) nimodipine, 16% (m/m) povidone K17 and 64% (m/m) of six different mixtures of polyethylene glycol 2000 and 8000 were prepared by the melting method and investigated by dissolution testing, thermal analysis and X-ray diffraction. As the solubility of povidone K17 in polyethylene glycol 2000 is about 70% at 65 degrees C and decreases with increasing molecular weight of the polyethylene glycol, mixtures containing different amounts of dissolved povidone K17 are obtained by varying the mixing ratio of polyethylene glycol 2000 and 8000. Recrystallization is inhibited in the formulations, containing mainly polyethylene glycol 2000 whereas recrystallization occurs in systems consisting predominantly of polyethylene glycol 8000. These results show clearly that dissolution of povidone in melted polyethylene glycol is a prerequisite in order to prevent recrystallization.
机译:先前的研究表明,通过添加聚维酮K17,可以有效地防止含有尼莫地平和聚乙二醇2000的固体分散体重结晶。这些系统的特点是溶出度高,药物在溶出介质中明显过饱和。所有聚乙二醇和聚乙烯吡咯烷酮的混合物能否达到这些特性仍是未知的。本研究的目的是发现在通过熔融方法制备固体分散体的过程中是否必须将聚维酮K17溶解在熔融的聚乙二醇中,以避免药物重结晶并确保储存稳定性。通过熔融法制备了由20%(m / m)尼莫地平,16%(m / m)聚维酮K17和64%(m / m)的六种不同的聚乙二醇2000和8000混合物组成的固体分散体,并通过溶解进行了研究测试,热分析和X射线衍射。由于聚维酮K17在聚乙二醇2000中的溶解度在65°C时约为70%,并且随着聚乙二醇分子量的增加而降低,因此通过改变聚乙二醇2000和8000的混合比可以获得含有不同量溶解聚维酮K17的混合物在主要包含聚乙二醇2000的制剂中重结晶受到抑制,而在主要由聚乙二醇8000组成的体系中发生重结晶。这些结果清楚地表明,聚维酮在熔融的聚乙二醇中的溶解是防止重结晶的先决条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号